Cindy Boer

226 | Chapter 5.1 41. Zhernakova A, et al. Population-based metagenomics analysis reveals markers for gut microbiome composition and diversity. Science. 2016;352:565–569. doi: 10.1126/science.aad3369.- DOI- PMC - PubMed 42. Falony G, et al. Population-level analysis of gut microbiome variation. Science. 2016;352:560–564. doi: 10.1126/science.aad3503.- DOI- PubMed 43. Medina-Gomez C, et al. Bone mass and strength in school-age children exhibit sexual dimorphism related to differences in lean mass: The Generation R Study. J. Bone Miner. Res. 2016;31:1099– 1106. doi: 10.1002/jbmr.2755.- DOI- PubMed 44. Medina-Gómez C, et al. BMD loci contribute to ethnic and developmental differences in skele- tal fragility across populations: assessment of evolutionary selection pressures. Mol. Biol. Evol. 2015;32:2961–2972. doi: 10.1093/molbev/msv170.- DOI- PMC- PubMed 45. Langille MGI, et al. Predictive functional profiling of microbial communities using 16S rRNA marker gene sequences. Nat. Biotechnol. 2013;31:814–821. doi: 10.1038/nbt.2676.- DOI- PMC- PubMed 46. Abubucker S, et al. Metabolic reconstruction for metagenomic data and its application to the human microbiome. PLoS Comput. Biol. 2012;8:e1002358–e1002358. doi: 10.1371/journal. pcbi.1002358.- DOI- PMC- PubMed 47. Segata N, et al. Metagenomic biomarker discovery and explanation. Genome Biol. 2011;12:R60. doi: 10.1186/ gb-2011-12-6-r60.- DOI- PMC- PubMed 48. Everard A, et al. Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity. Proc. Natl. Acad. Sci. USA. 2013;110:9066–9071. doi: 10.1073/pnas.1219451110.- DOI- PMC- PubMed 49. Anderson KL, Salyers AA. Biochemical evidence that starch breakdown by Bacteroides thetaiotaomicron involves outer membrane starch-binding sites and periplasmic starch-degrading enzymes. J. Bacteriol. 1989;171:3192–3198. doi: 10.1128/JB.171.6.3192-3198.1989.- DOI- PMC- PubMed 50. Chung WSF, et al. Modulation of the human gut microbiota by dietary fibres occurs at the species level. BMC Biol. 2016;14:3. doi: 10.1186/s12915-015-0224-3.- DOI- PMC- PubMed 51. Koropatkin NM, Cameron EA, Martens EC. How glycan metabolism shapes the human gut microbiota. Nat. Rev. Microbiol. 2012;10:323–335. doi: 10.1038/nrmicro2746.- DOI- PMC- PubMed 52. Xu J, et al. Evolution of symbiotic bacteria in the distal human intestine. PLoS Biol. 2007;5:e156–e156. doi: 10.1371/journal.pbio.0050156.- DOI- PMC- PubMed 53. Martínez I, et al. Gut microbiome composition is linked to whole grain-induced immunological improvements. ISME J. 2013;7:269–280. doi: 10.1038/ismej.2012.104.- DOI- PMC- PubMed 54. Chen W, Liu F, Ling Z, Tong X, Xiang C. Human intestinal lumen and mucosa-associated microbiota in patients with colorectal cancer. PloS One. 2012;7:e39743–e39743. doi: 10.1371/journal.pone.0039743. - DOI - PMC - PubMed 55. Murri M, et al. Gut microbiota in children with type 1 diabetes differs from that in healthy children: a case-con- trol study. BMC Med. 2013;11:46. doi: 10.1186/1741-7015-11-46.- DOI- PMC- PubMed 56. Hou AY, Kaczmarek JL, Khan NA, Holscher HD. Dietary fiber and the human gastrointestinal microbiota as pre- dictors of bone health. FASEB J. 2017;31:lb322. doi: 10.1096/fj.201601082R.- DOI 57. Bajaj JS, et al. Colonic mucosal microbiome differs from stool microbiome in cirrhosis and hepatic encephalop- athy and is linked to cognition and inflammation. Am. J. Physiol. Gastrointest. Liver Physiol. 2012;303:G675– G685. doi: 10.1152/ajpgi.00152.2012.- DOI- PMC- PubMed 58. Hong P-Y, Croix JA, Greenberg E, Gaskins HR, Mackie RI. Pyrosequencing-based analysis of the mucosal mi- crobiota in healthy individuals reveals ubiquitous bacterial groups and micro-heterogeneity. PloS One. 2011;6:e25042–e25042. doi: 10.1371/journal.pone.0025042.- DOI- PMC- PubMed 59. Nikaido H. Outer membrane barrier as a mechanism of antimicrobial resistance. Antimicrob. Agents Chemoth- er. 1989;33:1831–1836. doi: 10.1128/AAC.33.11.1831.- DOI- PMC- PubMed 60. Shivaramaiah HS, Relhan N, Pathengay A, Mohan N, Flynn HW. Endophthalmitis caused by gram-positive bacte- ria resistant to vancomycin: clinical settings, causative organisms, antimicrobial susceptibilities, and treatment outcomes. Am. J. Ophthalmol. Case Rep. 2018;10:211–214. doi: 10.1016/j.ajoc.2018.02.030.- DOI- PMC- Pu- bMed